MedTrace Logo

Pharmacokinetics and Safety Study of Apetrol ES

NCT02446353 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2015-05-18

No results posted yet for this study

Summary

A Randomized, Open Label, Single dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and Megace® in Healthy Male Volunteers.

Conditions

  • Healthy

Interventions

DRUG

Apetrol ES / Megace

Sequences of administered drugs

Sponsors & Collaborators

  • Severance Hospital

    collaborator OTHER

  • LG Life Sciences

    lead INDUSTRY

Principal Investigators

  • Kyungsoo Park, Ph D, MD · Yonsei University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-06-30
Completion
2010-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02446353 on ClinicalTrials.gov